OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16 25 years: a RCT - Efficacy and Mechanism Evaluation.

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

188 Downloads (Pure)

Original language	English
Article number	10.3310/THEI8200
Number of pages	146
Journal	Efficacy and Mechanism Evaluation
Volume	9
Issue number	6
DOIs	https://doi.org/10.3310/THEI8200
Publication status	Published - 5 Jul 2022

Access to Document

@article{c45a26dee61a4a6693a18cad997ac6bc,

title = "OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16 25 years: a RCT - Efficacy and Mechanism Evaluation.",

author = "Philip Asherson and Lena Johansson and John Strang and Sabine Landau",

year = "2022",

month = jul,

day = "5",

doi = "10.3310/THEI8200",

language = "English",

volume = "9",

journal = "Efficacy and Mechanism Evaluation",

issn = "2050-4365",

publisher = "NIHR Journals Library",

number = "6",

}

TY - JOUR

T1 - OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16 25 years: a RCT - Efficacy and Mechanism Evaluation.

AU - Asherson, Philip

AU - Johansson, Lena

AU - Strang, John

AU - Landau, Sabine

PY - 2022/7/5

Y1 - 2022/7/5

U2 - 10.3310/THEI8200

DO - 10.3310/THEI8200

M3 - Article

SN - 2050-4365

VL - 9

JO - Efficacy and Mechanism Evaluation

JF - Efficacy and Mechanism Evaluation

IS - 6

M1 - 10.3310/THEI8200

ER -